登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688347 证券简称：华虹公司 公告编号：2026-012 华虹半导体有限公司 2026年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次会议是否有被否决议案：无 一、会议召开和出席情况 （三）出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及其持有表决权数量的情 况： ■ （四）表决方式是否符合《公司法》及公司章程的规定，股东会主持情况等。 2026年第一次临时股东大会由华虹半导体有限公司（以下简称"本公司"或"公司"）董事会召集，由董事 会主席白鹏先生主持，采用现场投票与网络投票（仅针对A股股东）相结合的表决方式，本公司股东代 表、见证律师及香港股份过户登记处卓佳证券登记有限公司代表于股东大会上担任计票人及监票人。本 次股东大会的召集、召开和表决程序符合相关法律法规以及《华虹半导体有限公司之组织章程细则》的 有关规定。 （五）公司董事和董事会秘书的列席情况 1、公司在任董事8人，出席8人； 2、首 ...

Group 1 - The Sci-Tech Innovation Board Composite Index (Sci-Tech Index) has been operating smoothly for one year since its official release on January 20, 2025, and has become a key tool for investors to observe and share the dividends of China's new productive forces [2] - As of February 10, 2025, the Sci-Tech Index covers 580 samples with a market capitalization coverage exceeding 90%, and the weight of constituent stocks with a total market value above 10 billion yuan has increased by 15.1% since its release [2] - The index has gained recognition among investors, with a total of 49 fund managers launching 81 index funds related to the Sci-Tech Index, achieving a combined scale of 25.8 billion yuan as of February 9, 2025 [4] Group 2 - The Sci-Tech Board has gathered over 600 companies, with the latest addition being the listing of Yuhang Power on February 10, 2025, marking it as the 603rd listed company [5] - The total R&D investment of Sci-Tech Board companies reached 132.864 billion yuan in the first three quarters of 2025, which is 2.7 times the net profit of the board, with a median R&D investment ratio of 12.5% of operating income, significantly higher than other A-share sectors [5] - As of February 9, 2025, 391 companies on the Sci-Tech Board have disclosed their expected performance for 2025, with over 60% of them reporting a year-on-year increase in net profit [6] Group 3 - The integrated circuit and biopharmaceutical industries are experiencing a recovery in prosperity, with 87 companies in the integrated circuit sector expected to see a combined net profit increase of approximately 9.949 billion yuan due to demand from emerging applications like artificial intelligence [7] - In the innovative drug sector, 26 companies are projected to increase their net profit by 1.449 billion yuan in 2025, with 18 companies reporting a total revenue of 24.157 billion yuan, reflecting a year-on-year growth of 34.9% [7]

Core Viewpoint - Guangdong aims to establish two funds as patient, professional, targeted, and benchmark funds to support innovation and investment in key industries [1][2] Group 1: Fund Overview - The first fund is the Guangdong-Hong Kong-Macao Greater Bay Area Venture Capital Guidance Fund, with a total scale exceeding 50 billion yuan, set to operate by the end of 2025 [1] - The second fund is the Guangdong Strategic Emerging Industries Investment Guidance Fund, initiated by the Guangdong Development and Reform Commission and the Finance Department, with a total scale of 100 billion yuan and an initial registered capital of 50 billion yuan [1] Group 2: Investment Focus - The Guangdong-Hong Kong-Macao Fund has a 20-year lifespan, including a 10-year investment period and a 10-year exit period, focusing on early-stage projects in fields such as integrated circuits, artificial intelligence, and aerospace [1] - The Guidance Fund will primarily invest in the transformation and upgrading of traditional industries, as well as the cultivation of emerging and future industries in Guangdong [1] Group 3: Management and Operational Mechanisms - The management mechanism for the two funds will be optimized, incorporating innovative measures such as differentiated assessments and classified exits to enhance investment enthusiasm and innovation [2] - The Guangdong-Hong Kong-Macao Fund has already signed agreements for 10 sub-funds, while the first 10 billion yuan of the Guidance Fund's registered capital has been paid in [2]

2026.02. 10 本文字数：2754，阅读时长大约4分钟 作者 | 第一财经 黄思瑜 2月10日，随着新股电科蓝天（688818.SH）上市，科创板上市公司总数达到603家，总市值达到 11.44万亿元。 截至目前，科创板逾390家公司以业绩预告或快报形式披露了2025年度预计业绩情况，占板块公司 总数的超六成；另有1家公司披露了科创板2025年度首份年报。从细分行业表现看，集成电路、生 物医药行业景气度回升。 科创综指为观察科创板整体情况和发展态势提供了全局性的视角。截至2月10日，科创综指样本数量 达580只，市值覆盖度超过90%，总市值高于100亿元的科创综指成份股权重占比较发布时提升 15.1%。 东吴证券首席经济学家、研究所联席所长芦哲对第一财经称，预期未来3～5年，科创板总市值有望 翻倍，科创综指将同步成长为"万亿级产品规模、千亿级日成交"的核心宽基指数，不仅与沪深 300、创业板指并驾齐驱，更可能率先完成"本土指数—跨境ETF—全球定价"的三级跳，成为中国科 技创新实力对外展示的"首张名片"。 391家公司"交卷"，六成预增 目前，科创板上市公司数量合计603家，包括61家未盈利企业、9家 ...

2月10日，科创板又迎来新兵电科蓝天。目前，科创板上市公司总数达到603家。 作为中国"硬科技"企业的聚集地，科创板的板块产业图谱与现代化产业体系建设同向而行，尤其在新一 代信息技术、生物医药、高端装备制造等战略性新兴产业，已形成"链主引领、上下协同"的发展格局。 科创综指为观察科创板整体情况和发展态势提供了全局性的视角。推出一年来，科创综指的市场关注度 持续提升，截至2026年2月10日，科创综指样本数量达580只，市值覆盖度超过90%，总市值高于100亿 元的科创综指成份股权重占比较发布时提升15.1%，成长效应显著。 科创综指已成为与上证指数、深证成指、创业板指并列的A股四大核心宽基指数，为境内外投资者观测 和分享中国新质生产力发展红利提供了重要工具。 科创板近六成公司预告净利润同比增长 科创综指是定位于覆盖科创板全市场的综合指数，板块市值覆盖度超过90%。可以说，科创综指是分享 科创板公司成长发展成果的有力指标。 截至2026年2月9日，科创板共有391家公司以业绩预告或快报形式披露了2025年度预计业绩情况，占板 块公司总数的六成以上；另有1家公司芯导科技披露了科创板2025年度首份年报，以营收同比 ...

上证报中国证券网讯（记者 严曦梦）2月10日，以"赋新质启新程"为主题的2026张江科创金融沙龙在上海张江科学城举行。张通社联合加冕研究院第八年发 布《2025年张江企业融资榜单》（以下简称《榜单》）。 《榜单》基于公开融资事件数据，从融资规模、资本投向、融资阶段、企业质量与创新特征，以 及投资机构参与情况等多个维度，全面呈现张江科创金融生态的最新图景。 全年融资237起约占上海四分之一 根据《榜单》，2025年张江共有210家科创企 业完成融资，全年发生237起融资事件，披露融资金额278亿元；融资事件数同比增长30%，披露融资金额同比增长18%。 观察张江的全年表现，融资节奏呈 现出高度的均衡性与连续性，未出现阶段性的"冲量"或断档。平均每月约20起融资事件，反映出张江持续有项目在推进、有投资在落地。 从区域贡献看， 2025年张江融资规模约占浦东新区的65%，约占上海市的25%。这意味着，上海每4起科创融资中，就有1起发生在张江。 三大先导产业融资占比超九成 生 物医药最活跃 《榜单》显示，2025年，张江科创融资的行业投向更趋集中，发生在生物医药、人工智能、集成电路等上海三大先导产业的融资件数合计占 ...

Core Insights - Zhuhai is at a critical juncture as it aims to boost its economy, with signs of new growth momentum emerging after a period of transformation [1] - The government work report outlines ambitious GDP growth targets and investment plans for the coming years, emphasizing the need for a robust industrial foundation and innovation [2][3] Economic Performance - In 2025, Zhuhai's GDP is projected to reach 457.31 billion yuan, with a year-on-year growth of 2.7%, slightly lower than neighboring Zhongshan [1] - Key economic indicators such as industrial added value, foreign trade, and public budget revenues have shown growth, but fixed asset investment has declined by 31.6% [1] - The "4+3" pillar industries are expected to grow by 6%, with integrated circuits and high-end equipment manufacturing industries seeing growth rates exceeding 20% [1] Investment and Innovation - Zhuhai aims for a GDP growth target of 5%-5.5% by 2026, with specific goals for industrial added value, fixed asset investment, and retail sales [2] - The city has seen over 80% growth in R&D investment over five years, with an R&D intensity of 4.57%, ranking second in the province [5] - The government emphasizes the need to enhance the conversion of technological advantages into market advantages, addressing low technology transfer rates [5] Industrial Development - The government work report highlights the need to strengthen pillar industries, particularly in renewable energy, biomedicine, and integrated circuits [3][4] - There is a focus on advancing technology in the semiconductor sector and fostering innovation in biomedicine and health [3] Cross-Border Cooperation - Zhuhai's strategic location allows it to connect mainland China with Hong Kong and Macau, enhancing its role in the Guangdong-Hong Kong-Macau Greater Bay Area [6] - The city plans to improve customs efficiency and enhance logistics and tourism services through the Hong Kong-Zhuhai-Macao Bridge [6][7] - Collaborative efforts with Hong Kong and Macau are aimed at building a high-efficiency production and consumption service trade system [7] Future Prospects - The government aims to establish a comprehensive ecosystem for innovation and entrepreneurship, leveraging its geographical advantages and existing industrial base [6][8] - The integration of Zhuhai and Macau is seen as a way to develop a low-altitude economy, providing unique cross-border application scenarios [8][9] - Zhuhai's ability to navigate its transformation challenges may serve as a model for other medium-sized cities in China [9]

"未来3～5年科创综指相关产品规模和体量仍有巨大发展空间。" 2月10日，随着新股电科蓝天（688818.SH）上市，科创板上市公司总数达到603家，总市值达到11.44万 亿元。 截至目前，科创板逾390家公司以业绩预告或快报形式披露了2025年度预计业绩情况，占板块公司总数 的超六成；另有1家公司披露了科创板2025年度首份年报。从细分行业表现看，集成电路、生物医药行 业景气度回升。 科创综指为观察科创板整体情况和发展态势提供了全局性的视角。截至2月10日，科创综指样本数量达 580只，市值覆盖度超过90%，总市值高于100亿元的科创综指成份股权重占比较发布时提升15.1%。 东吴证券首席经济学家、研究所联席所长芦哲对第一财经称，预期未来3～5年，科创板总市值有望翻 倍，科创综指将同步成长为"万亿级产品规模、千亿级日成交"的核心宽基指数，不仅与沪深300、创业 板指并驾齐驱，更可能率先完成"本土指数—跨境ETF—全球定价"的三级跳，成为中国科技创新实力对 外展示的"首张名片"。 391家公司"交卷"，六成预增 目前，科创板上市公司数量合计603家，包括61家未盈利企业、9家特殊股权架构企业、7家红筹企业、 ...

中新网上海2月10日电张江硬核吸金力凸显，成为上海乃至中国科创资本的核心集聚高地。 在10日举行的2026张江科创金融沙龙上，《2025年张江企业融资榜单》对外发布。该榜单显示，2025 年，张江210家企业完成237起融资，披露金额达278亿元。 数据显示，张江企业的融资规模占浦东新区全区65%、上海全市25%，成为区域科创融资的核心引擎。 超512家投资机构参与张江投融资，国有资本、产业资本、市场化创投机构多元布局，资本结构持续优 化。 资本高度聚焦硬核科技赛道，生物医药、人工智能、集成电路三大先导产业融资合计占比91%，较2024 年提升9个百分点，其中生物医药以85起融资居首。融资阶段呈现早中后期协同集聚特征，早期融资占 比64%，彰显资本对张江初创科创企业的信心。 融资企业的科创硬实力成为吸金关键，其中8家实现全球首个技术突破、9家填补国内产业空白，还涵盖 75家高新技术企业、27家专精特新"小巨人"及33家独角兽企业，科创动能持续释放。 亮眼的融资成绩，源于张江构建的覆盖企业全生命周期的创新服务生态。上海市张江科学城建设管理办 公室主任、中国(上海)自由贸易试验区管理委员会张江管理局局长肖健表示， ...

截至2026年2月9日，科创板中共有391家公司以业绩预告或快报形式披露了2025年度业绩预测。已披露业绩预测的科创板公司中，近六成公司净利润实现 同比增长，其中39家净利润大幅增长100%以上、51家扭亏为盈。科创成长层企业中，寒武纪、奥比中光、精进电动、诺诚健华4家公司预计将在年报披露 后实现"摘U"。 从细分行业表现看，科创板集成电路、生物医药行业景气度回升。其中，集成电路产业受人工智能等新兴应用需求拉动，延续较高景气度，87家已披露业 绩预测的公司，合计净利润同比增加约99.49亿元，57家公司业绩预增或扭亏为盈。创新药行业受益于BD交易频出、出海提速，商业化进程显著加快，26 家公司合计净利润增加14.49亿元，18家披露营业收入的公司合计实现营业收入241.57亿元，同比增长34.9%。 科创综指也是分享改革红利的重要牵引。科创板自设立以来先后推进试点注册制、"科创板八条"、"科创板1+6"三轮系统性改革，着力提高资本市场制度 包容性、适应性。截至2月10日，科创板累计支持61家未盈利企业、9家特殊股权架构企业、7家红筹企业、23家第五套标准企业上市。未盈利上市企业中 22家上市后成功盈利"摘U" ...